baber/WOPTO huggingface dataset:
Patent FI-920896-A0 (FI)
Inventor: MYLLYMAEKI MATTI
IPC: G08B21/04
Filed: 1992-02-28
Abstract: PCT No. PCT/FI93/00067 Sec. 371 Date Aug. 24, 1994 Sec. 102(e) Date Aug. 24, 1994 PCT Filed Feb. 26, 1993 PCT Pub. No. WO93/16636 PCT Pub. Date Sep. 2, 1993.The present invention relates to a wrist-held monitoring device for independently observing the physical condition of a person by means of motoric activity or movement and physiological conditions, e.g., temperature and/or electric conductivity of the skin. The anomalous condition data is transmitted by conventional techniques on a radio frequency message to one or more receivers, which either set off a local alarm or further transfer the data by conventional techniques to a centralized receiving point for alarm generation there.
Patent FI-922319-A0 (FI)
Inventor: HYPPAENEN TIMO
IPC: F22B31/00
Filed: 1992-05-21
Abstract: PCT No. PCT/FI93/00208 Sec. 371 Date Nov. 4, 1994 Sec. 102(e) Date Nov. 4, 1994 PCT Filed May 18, 1993 PCT Pub. No. WO93/23703 PCT Pub. Date Nov. 25, 1993Method and apparatus for providing a gas seal in a CFB reactor, which is provided with a vertical, slot-shaped return duct (16), and for regulating the flow of circulating mass therein. The gas seal (22) is formed by arranging barrier means (22, 24, 26) on two different levels in the regulation zone of the return duct to slow down the flow of the circulating mass through the regulation zone. The flow of the circulating mass through the regulation zone is regulated by injecting fluidizing gas (56, 58, 60) into the regulation zone.
Patent FI-925009-A0 (FI)
Inventor: CHEONG CATHERINE L
IPC: A61L15/16
Filed: 1992-11-05
Abstract: A wound dressing has a wound-contact layer formed from a polyurethane foam. The foam comprises one part by weight of the reaction product of an isocyanate-capped prepolymer with water (and optionally other hydroxy-functional compounds), and from 0.03 to 0.3 parts by weight of a natural or synthetic rubber. The isocyanate-capped prepolymer is preferably an isocyanate-capped ethyleneoxy/propyleneoxy copolymer, and the rubber is preferably an acrylic rubber.
Patent FI-930345-A0 (FI)
Inventor: QUINN ROBERT E
IPC: C07C303/44
Filed: 1993-01-27
Abstract: A process for the preparation of a purified monomer is disclosed which comprises the steps of reacting an impure monomerwherein R1 and R2 are independently hydrogen or alkyl groups containing from 1 to about 6 carbon atoms, with(B) a substantially aqueous solution of an oxide or hydroxide of the structure MO or MOH wherein M is a Group IA or Group IIA metal, or an amine of the structure NR3R4R5 wherein R3, R4 and R5 are independently hydrogen or alkyl, alkanol or alkoxy groups containing from 1 to about 12 carbon atoms,wherein the molar ratio of (A):(B) is from about 1:1-2 for Group IA metals, 2:1-2 for Group IIA metals or ratio of moles of (A) to nitrogens of (B) is from about 1:1-2 nitrogens to form a salt, wherein in order to prevent polymerization of (A), the purified monomer or both or prevent undesired side reactions, the reaction of (A) and (B) occurs at a temperature of between about -20 to 75° C. and at a pH between about 7 to about 12.5, and recovering a purified salt by crystallization in the presence of an oxygen bearing gas stream by subjecting the aqueous solution to changes in temperature and/or pressure and/or concentration.
Patent FI-930458-A0 (FI)
Inventor: DOWELL TERESA JOLANTA
IPC: C09K23/16
Filed: 1993-02-02
Abstract: An opacifier comprising an amine including at least one carbon chain of at least 16 carbon atoms or a fatty amidoamine having an alkyl group including at least about thirteen carbon atoms, and a suitable acid is disclosed. The opacifier is a salt of the long-chain amine and effectively opacifies, or pearlizes, water-based compositions, such as hair treating compositions, like shampoos, conditioners, conditioning shampoos and antidandruff shampoos; and skin treating compositions, like conditioners, moisturizers and topical medicaments.
Patent FI-940705-A0 (FI)
Inventor: KOIVU VESA
IPC: H04W24/00
Filed: 1994-02-15
Abstract: PCT No. PCT/FI94/00399 Sec. 371 Date May 10, 1995 Sec. 102(e) Date May 10, 1995 PCT Filed Sep. 12, 1994 PCT Pub. No. WO95/08246 PCT Pub. Date Mar. 23, 1995A method for supervising base station radio channels to detect channels with interference and/or poor quality, by measuring and analysing connections separately for each radio channel. For instance, radio channels with poor quality and/or interference in the frequency hopping sequence can be detected, eliminated from the frequency hopping sequence, and replaced by others, while the poor quality and/or interference remains a problem.
Patent FI-945163-A0 (FI)
Inventor: BUXTON FRANK
IPC: C12N1/15
Filed: 1994-11-02
Abstract: The present invention concerns a novel DNA sequence coding for an Aspergillus aspartic protease, an Aspergillus aspartic protease per se and a method for the preparation thereof. The invention further concerns a novel Aspergillus mutant strain defective in a protease of the aspartic proteinase-type, which is useful for the expression of heterologous protein, and a method for the preparation of such a mutant strain.
Patent FI-945705-A0 (FI)
Inventor: FAUL MARGARET MARY
IPC: C07C41/16
Filed: 1994-12-02
Abstract: The present invention provides a novel synthesis of the compounds of Formula (I): <CHEM> The compounds are produced in high yield and without utilizing expensive chromatographic separations. The synthesis is particularly advantageous because it is stereoselective.
Patent FI-955713-A0 (FI)
Inventor: SERRES ALAIN
IPC: B01F23/30
Filed: 1995-11-27
Abstract: The injector consists of a duct with convergent and divergent sections (2a,2c) and an air inlet chamber (3a). The duct is made from a cylindrical tube (1) with convergent and divergent inner surfaces linked by a cylindrical section (2b), with the air inlet chamber (3a) situated in a step (3) of greater diameter than the convergent section to which it is connected. Just before the point at which it joins the convergent section the step has a tangential aperture (5), and it is closed by a stopper (6) with channels (8) through it for the pulp to be fed through. A number of injectors are enclosed in a sealed housing formed from two plates (10,11) connected by a shell and fed with air through a duct.
Patent FI-962176-A0 (FI)
Inventor: KARLSSON MARKKU
IPC: D21F1/66
Filed: 1996-05-23
Abstract: A method in a paper machine for arrangement of water circulation therefor and arrangement of a water circulation system in a paper machine. In view of full or partial closing of the water circulations in a paper machine, the wash water flows from the fabrics and from other devices in the paper machine as well as the water drained from the paper web to be produced are recovered selectively based on the place of origin thereof in the paper machine. At least a part of the recovered different water flows are cleaned, and the cleaned water flows are recirculated to applications of reuse suitable in view of their washing potential in the papermaking process.
Patent FI-962375-A0 (FI)
Inventor: KLOPFENSTEIN TERRY JAMES
IPC: A23K1/18
Filed: 1996-06-07
Abstract: A ruminally inert fat for a ruminant feed is made by applying reducing sugars to oilseed meats and heating to induce non-enzymatic browning. The process is controlled to ensure penetration of the reducing sugars into the interior of cracked oilseed meat prior to browning. The browning reaction renders the protein which surrounds the oil resistant to rumen bacterial degradation to thereby encapsulate the oil in a protective matrix.
Patent FI-970785-A0 (FI)
Inventor: MOLDT PETER
IPC: C07D471/04
Filed: 1997-02-25
Abstract: PCT No. PCT/EP95/03594 Sec. 371 Date May 20, 1997 Sec. 102(e) Date May 20, 1997 PCT Filed Sep. 12, 1995 PCT Pub. No. WO96/08495 PCT Pub. Date Mar. 21, 1996The present patent application discloses compounds having the formula   <IMAGE>   or a pharmaceutically acceptable salt thereof wherein R1 is hydrogen, alkyl or benzyl; X is O or NOR2, wherein R2 is hydrogen, alkyl or benzyl; Y is N-R4 wherein R4 is hydrogen, OH or alkyl; n is 0 or 1; R6 is phenyl which is substituted one or more times with substituents selected from the group consisting of SO2NR'R'', CONR'R'', and COR'''wherein R' and R'' each independently are hydrogen, alkyl, or -(CH2)p-W, wherein p is 0, 1, 2, 3, 4, 5, or 6, and W is hydroxy, amino, alkoxycarbonyl, or phenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy or methylenedioxy; or wherein R' and R'' together is (CH2)rZ(CH2)s wherein r and s each independently are 0, 1, 2, 3, 4, 5, or 6 and Z is O, S, CH2 or NR'''' wherein R'''' is hydrogen, alkyl, or -(CH2)p-W, wherein p is 0, 1, 2, 3, 4, 5, or 6, and W is hydroxy, amino, alkoxycarbonyl, or phenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy or methylenedioxy; and wherein R''' is hydrogen, alkyl, alkoxy or phenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy or methylenedioxy; A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b. The compounds are useful in the treatment of cerebrovascular disorders for example.
Patent FI-972959-A0 (FI)
Inventor: GOOLSBY TERRY L
IPC: C10G11/05
Filed: 1997-07-11
Abstract: A catalytic cracking catalyst comprising zeolite, kaolin, alumina and/or silica, antimony and 100-5,000 wt. ppm Ni is disclosed. The Ni-antimony interact in the environment of a fluidized catalytic cracking reactor to increase the magnetic susceptibility of the catalyst, permitting removal of nickel contaminated catalyst by magnetic separation.
Patent FI-980452-A0 (FI)
Inventor: HUTCHINSON DOUGLAS K
IPC: A61K31/454
Filed: 1998-02-27
Abstract: New 3-(heterocyclyl-phenyl)-oxazolidin-2-on-5-yl-methylamide derivatives of formula (I) and their salts are new: X = NR1, S(O)g, or O; R1 = H, 1-6C alkyl (opt. substd. by OH, halo, or cyano), aryl 1-4C alkyl, COR11, COOR12, CO(CH2)hCOR11, 1-6C alkylsulphonyl, aryl 1-4C alkylsulphonyl, Het, or Het-CO; R12 = 1-6C alkyl (opt. substd. by OH, halo, or cyano), (CH2)h-aryl or (CH2)hOR13; R11 = R11 or H; R13 = H, 1-6C alkyl, (CH2)h-aryl or 2-7C alkylcarbonyl; R2 = H, 1-6C alkyl, (CH2)h-aryl or halo; R3, R4 = H or halo; R5 = H, 1-12C alkyl (opt. substd. by \- 1 halo), 3-12C cycloalkyl or 1-6C alkoxy; g = 0-2, h = 1-4; and m, n = 0-5, provided that m + n = 1-5. 85 Cpds. (I) are specifically claimed e.g. (S)-N-[[3-[3-fluoro-4-[1-carboxymethyl-3-(3-methyl)-azetidinyl]phenyl]2-oxo-5-oxazolidinyl]methyl]acetamide; (S)-(-)-N-[[3-[4-[1-(hydroxyacetyl)-4-piperidinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide and (S)-(-)-N-[[3-[4-[1-(hydroxyacetyl)-3,6-dihydro-2H-pyridin-4-yl]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide.
Patent IL-60616-A0 (IL)
Title: Acollagen solution,process for its manufacture and its use
IPC: C07K14/745
Filed: 1980-07-17
Abstract: Process for the manufacture of a collagen solution and its use for the manufacture of collagen fibrillae for adsorbing coagulation factors, as diagnostic agent, for the manufacture of a collagen sponge and for use in a cosmetic preparation.
Patent IL-71950-A0 (IL)
Title: 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
IPC: A61K31/455
Filed: 1984-05-29
Abstract: A 1,4-dihydropyridine derivative of the formula   <IMAGE>   in which R and R1 each independently is hydrogen, C1-C4-alkyl, C1 to C12-alkoxy, C1-C4-halogenoalkoxy, halogen, nitro, trifluoromethyl, <IMAGE>   <IMAGE>  X is oxygen or sulphur, R4 and R5 each independently is hydrogen, C1-C4-alkyl, C1-C6-alkoxy, halogen, trifluoromethyl, amino or nitro, and R2 and R3 each independently is hydrogen, a C1-C10-alkyl, C2-C10-alkenyl or C3-C10-alkinyl radical which is optionally substituted by halogen, hydroxyl, C1-C4-alkoxy, amino, mono- and di-C1-C4-alkylamino, carbo-C1-C6-alkoxy and/or nitro, a C3 to C6-membered cycloalkyl radical, a phenyl radical which is optionally substituted by C1-C4-alkyl, C1-C6-alkoxy, halogen, amino and/or nitro, or a phenyl-C1-C3-alkyl radical, or a carbohydrate radical which is optionally bonded via a C1-C8-alkyl chain to the amide nitrogen atom or a pharmaceutically acceptable acid addition salt thereof, which improves the contractility of the heart, raises the blood pressure, lowers the blood sugar, reduces the swelling of mucous membranes and affects the salt and fluid balances of a patient.
Patent IL-83605-A0 (IL)
Title: Purified thermostable enzyme and process for amplifying,detecting,and/or cloning nucleic acid sequences using said enzyme
IPC: C12N9/96
Filed: 1987-08-21
Abstract: A stable enzyme composition is disclosed that comprises a thermostable nucleic acid polymerase enzyme in a buffer comprising non-ionic polymeric detergents.
Patent IL-85132-A0 (IL)
Title: Triazolyl derivatives,their preparation and their use as microbicides
IPC: C07D521/00
Filed: 1988-01-19
Abstract: 1. Claims for the Contracting States : DE, GB, FR, IT, NL, SE, LI, CH, BE, AT, LU, GR 1-phenoxyphenyl-1-triazolylmethyl-carbinols of formula I   see diagramm : EP0275955,P12,F4   in which R1 is fluorine, chlorine or bromine, R2 is fluorine, chlorine, bromine or methyl, and the acid addition salts with phytophysiologically tolerable organic and inorganic acids. 1. Claims for the Contracting State : ES A process for the preparation of the 1-phenoxyphenyl-1-triazolylmethyl-carbinols of formula I   see diagramm : EP0275955,P13,F5   in which R1 is fluorine, chlorine or bromine and R2 is fluorine, chlorine or bromine or methyl and acid addition salts thereof, characterised in that 1H-1,2,4-triazole or a metal salt thereof is condensed with a 4-phenoxy-acetophenone of formula II   see diagramm : EP0275955,P14,F1   in which R1 and R2 have the meanings given above and X is a nucleofugal leaving group, and the resulting 2-(diphenyl ether)-1-(1H-1,2,4-triazol)-ethan-2-one of formula IV   see diagramm : EP0275955,P14,F2   in which R1 and R2 have the meanings given above is reduced with hydrogen or a hydrogen donor.
Patent IL-87878-A0 (IL)
Title: Non-aqueous polymeric dispersion,its manufacture and use
IPC: C09D167/08
Filed: 1988-09-29
Abstract: A non-aqueous dispersion suitable for modifying alkyd-containing coating formulations and a method for manufacturing the non-aqueous dispersion are provided. The non-aqueous dispersion contains from about 10 to about 60 parts by weight of a low molecular weight solution polymer, having a selected glass transition temperature no less than about -10 DEG C, and from about 90 to about 40 parts by weight of a polymer which is insoluble in the non-aqueous medium, and where the soluble polymer is attached to or adsorbed onto the insoluble polymer particles. The non-aqueous dispersion is preferably prepared by dispersion polymerization to form the insoluble polymer in a non-aqueous medium in the presence of the soluble polymer.
Patent IL-95582-A0 (IL)
Title: Benzopyranone-beta-d-thioxylosides,their preparation and their use in therapy
IPC: C07D311/18
Filed: 1990-09-04
Abstract: The invention relates to the benzopyranone  beta -D-thioxyloside compounds of the following formula as new industrial products: 
<IMAGE>
 in which 
 
   - one of the substituents R or R' represents an oxygen atom doubly bonded to the ring carbon and the other represents a group R1 
   - the symbol
 ---
 represents a double bond conjugated to the CO group represented by one of the substituents R or R', 
   - X represents a sulphur atom or an oxygen atom, 
   - R1 and R2, which may be identical or different, each represent a hydrogen atom, a C1-C4alkyl group, a halogen atom, a trifluoromethyl group or a phenyl group, it being possible for R1 and R2, considered together and with the benzopyranone group to which they are linked, to form a 7,8,9,10-tetrahydrodibenzo[b,d]pyran-6-one group or a 1,2,3,4-tetrahydro-9H-xanthen-9-one group; and 
   - Y represents a hydrogen atom or an aliphatic acyl group. 
 
<??>These compounds are useful in therapy, in particular as venous antithrombotic agents.
Patent IL-99838-A0 (IL)
Title: Process for the manufacture of pesticidal 1-(alkoxymethyl) pyrrole compounds
IPC: A01N43/36
Filed: 1991-10-24
Abstract: There is provided a single step procedure for the manufacture of 1-(alkoxymethyl)pyrrole compounds by reacting the appropriate pyrrole precursor with a dihalomethane reagent in the presence of an alkali metal alkoxide. The 1-(alkoxymethyl)pyrrole compounds are useful as molluscicidal, insecticidal, acaricidal and nematocidal agents.
Patent SE-9802297-A0 (SE)
Title: Optiskt höghastighetsväxlingssystem för ATM-trafik
Inventor: HOLENDER WLODEK
IPC: H04L49/201
Filed: 1998-06-26
Abstract: 31 Sammanfattningsvis erfordrar en utf8ringsform av foreliggande uppfinning att var och en av informationsbitarna moduleras optiskt med anvandande av nagot av adresseringsmonstren sasom de som illustreras i FIGURERNA 11, 13 eller 15. Sasom visats ovan medger anvandningen av vane sadan uppsattning av kodningsmOnster en exakt upplosning av bilder som skapats genom Overlagring av kombinationer av de grundlaggande kodningsmonstren. Eftersom nyttolastdelen av vane ATM-cell vanligtvis riktas till en enda destinationsadress kan det ibland vara onocligt att modulera var och en av nyttolastbitarna i en ATM-cell med de optiska monster A, B, C eller D som illustreras i FIGURERNA 11, 13 eller 15. Istallet kan det vara tillrackligt om ett visst omrade av det grundmOnster som ãr till hjdlp for de svartade delarna som visas i FIGURERNA 17, 18 eller 19 innehaller destinationsadressbilden. I sadana fall kan en sadan kombinerad bild rundsandas till alla de optiska avkodarna 931 till 934 genom den optiska bildkopplaren 920. Den ldmpliga optiska avkodaren pa destinationssidan skulle ocksa ldsa in de grundldggande data och overfora dessa till den lampliga multiplexeraren medan de aterstaende optiska avkodarna helt enkelt skulle ignorera de data som rundsands till dem. Emellertid skulle anvandningen av detta omodulerade overforingsprotokoll erfordra att endast en ATM-cell vdxlas vid vane given tidpunkt. Fastan en foredragen utforingsform av forfarandet och apparaten enligt foreliggande uppfinning har illustrerats i de medfoljande ritningarna och beskrivits i den foregaende detaljerade beskrivningen sá bor det fOrstas att uppfinningen inte an begransad till den eller de visade utforingsformerna utan kan inrymma ett flertal omstruktureringar, modifikationer och substitutioner utan att avvika fran uppfinningens andemening sasom den framldggs och definieras genom de foljande patentkraven.
Patent AU-PP785098-A0 (AU)
Title: Treatment of heart disease
IPC: A61K38/19
Filed: 1998-12-21
Abstract: A method of causing cardiomyocyte growth and/or differentiation, the method comprising exposing a cardiomyocyte to neuregulin (NRG) thereby activating the MAP kinase pathway in the cardiomyocyte and causing growth and/or differentiation of the cardiomyocyte. Use of neuregulin, neuregulin polypeptide, neuregulin derivates, or compounds which mimic the activities of neuregulins in the treatment or management of heart disease and heart failure in a mammal.
Patent FI-20010926-A0 (FI)
Inventor: ANNOLA JOHANNA
IPC: H04L12/56
Filed: 2001-05-03
Abstract: The object of the invention is a method where a first communications device (10) and a second communications device (20), previously unknown to each other, communicate with each other wirelessly using short-range RF technology, said second communications device being at a certain moment of time in a first mode where the address of said second communications device is determinable by means of an inquiry wirelessly sent to it. In the method, the first communications device (10) sends (31) a first message in order to determine the address of said second communications device, said second communications device (20) receives (32) the first message, and said second communications device (20) generates and sends (33) to the first communications device a second message in response to the first message, the second message containing the address of said second communications device. In the method, a connection establishment process (35-38) is executed to establish a connection between the first communications device and said second communications device. During the connection establishment process, or in response to successful completion of the connection establishment process, at least one of said first and second communications devices (10, 20) switches (40) from said first mode into a second mode, in which second mode, the communications device that has switched into said second mode does not respond to messages arriving at it which have been sent to discover the address of the communications device that has switched into said second mode.   <IMAGE>
Patent FI-20021518-A0 (FI)
Inventor: KULOMAA MARKKU
IPC: C07K14/465
Filed: 2002-08-23
Abstract: The present invention relates to new mutants of biotin binding proteins with improved properties, e.g., thermally stabilized compared to wild type proteins. Proteins, which bind biotin include chicken avidin and bacterial streptavidin, other poultry avidins, such as avidin proteins isolated from the duck, goose, ostrich and turkey, and chicken avidin-related proteins (AVRs).
Patent FI-20065172-A0 (FI)
Inventor: PANULA ERKKI-JUSSI
IPC: F24V50/00
Filed: 2006-03-16
Abstract: A system for a low-energy network includes a collector circuit (1a, 1b) filled with a first transfer solution, a heat transfer circuit (7) filled with a second transfer solution, and a terminal (3) adapted to transfer heat between the transfer solutions of the collector circuit (1a, 1b) and the heat transfer circuit (7). The collector circuits (1a, 1b) are connected to the terminal via two distribution reservoirs (82, 81), of which the first distribution reservoir (81) is isolated and configured to receive and transfer heated transfer liquid, and the second distribution reservoir (82) is configured to receive and transfer cooled transfer liquid, and at least one collector circuit (1a, 1b) connecting the first distribution reservoir (81) and the second distribution reservoir (82) is connected to each distribution reservoir (81, 82) terminating the low-energy network. The system may also include a distribution tank (80) for the low-energy network.
Patent FI-20075199-A0 (FI)
Filed: 2007-03-27
Abstract: A support frame (1 ) for supporting and/or fastening horizontal bars, which support frame (1 ) comprises first and second flange parts (2, 4) extending in the longitudinal direction of the support frame (1 ) and a web (6) extending between them. The web (6) of the support frame (1 ) comprises flexible structure for altering the width of the support frame (1 ) and/or the distance between the first and second flange parts (2, 4). In an embodiment, the web comprises spring elements (8) that are arranged to flex in the lateral direction of the support frame (1 ) for altering the distance between the first and second flange parts (2, 4).
Patent FI-20110155-A0 (FI)
Inventor: VALTONEN TUOMAS PHILIP
IPC: G06F/
Filed: 2011-05-04
Abstract: A method for controlling a user interface capable of displaying digital content is presented. The method comprises: a) associating items of the digital content and metadata related to the items with virtual 3D objects capable of being shown on a display so that a visual expression of three- dimensionality is provided to a user, b) interlinking at least two of said virtual 3D objects by matching the metadata associated with these virtual 3D objects according to given criteria, c) controlling the display to show the interlinked virtual 3D objects, d) determining functionality on the basis of the metadata matching the given criteria and causing the at least two of the virtual 3D objects being interlinked, and e) controlling the user interface to carry out the determined functionality.